Image Têtière

Institut Mérieux founded Mérieux Développement, an investment company in the health care field, to leverage its entrepreneurial vision, bio-industrial experience, and international network in the pursuit of innovation. Mérieux Développement works alongside innovative entrepreneurs and companies whose products and services represent progress in patient and consumer health around the world.

It focuses on the four following areas:

  • Therapeutic Intervention & Patient Management
  • Life Science Tools & Diagnostic
  • Nutrition & Preventive Medicine
  • Contract Manufacturing & Pharma Services

In its investment policy, Mérieux Développement favors a long-term industrial vision and supports teams driven by passion and a shared vision of the business model. It helps entrepreneurs speed up the development of innovation and expand their companies at the international level.

Mérieux Développement today offers two activities fully dedicated to healthcare investment: Mérieux Equity Partners (capital innovation and capital development), and M2care (venture studio).

Mérieux Equity Partners

Owned at 60% by Institut Mérieux (via Mérieux Developpement)

Business activity

Capital innovation and capital development within healthcare and nutrition sectors.

Since 2010, Mérieux Equity Partners, affiliate of Mérieux Développement, has supported c. 40 companies in Venture, Growth and Buy-Out Capital. The company currently has over € 1 billion assets under management*.

(*) Updated data as of March 1st, 2022


Owned at 40% by Institut Mérieux (via Mérieux Developpement)

Business activity

Venture studio in the HealthTech sector. Support and investment in innovative projects


M2care co-founds, co-develops and co-finances innovative projects in their early stages of maturity. Its team builds bridges between the academic world, investors and manufacturing companies, to foster innovation at the service of public health and patients.